Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 1/20 | 0.61 |
| ▸ | TBXA2R | P21731 | 2/20 | 0.51 |
| ▸ | HTR3A | P46098 | 1/20 | 0.51 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.51 |
| ▸ | HRH1 | P35367 | 8/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 6/20 | 0.50 |
| ▸ | CHRM1 | P11229 | 6/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.49 |
| ▸ | DRD2 | P14416 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9541940 | 0.84 | RAB9A (0.53) | RAB9ATBXA2RHTR3AALOX5APHRH1 | |
| SCHEMBL3718063 | 0.77 | RAB9A (0.67) | RAB9ATBXA2RHTR3AALOX5APHRH1 | |
| SCHEMBL7756931 | 0.77 | TNF (0.64) | LMNAMAPTTP53ALDH1A1SMN1; SMN2 | |
| SCHEMBL7761652 | 0.76 | TP53 (0.63) | RAB9AHTR3AALOX5APHRH1CYP2D6 | |
| SCHEMBL7761087 | 0.76 | GALR3 (0.67) | RAB9ATBXA2RHRH1CYP2D6KCNH2 | |
| SCHEMBL8881382 | 0.76 | RAB9A (0.65) | RAB9ATBXA2RHTR3AALOX5APHRH1 | |
| SCHEMBL9537915 | 0.76 | RAB9A (0.65) | RAB9ATBXA2RHTR3AALOX5APHRH1 | |
| SCHEMBL9630558 | 0.76 | TNF (0.75) | RAB9ATBXA2RHTR3AALOX5APHRH1 | |
| SCHEMBL24041745 | 0.75 | CYP2C9 (0.54) | RAB9ACYP2D6LMNAMAPTTP53 | |
| SCHEMBL30195176 | 0.75 | GALR3 (0.68) | RAB9ATBXA2RALOX5APLMNATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11000529-B2 | Human papilloma virus replication inhibitors | Icosagen Cell Factory Oü (EE) | 2021-05-11 | — | — | US | disclosed |
| US-20200046730-A1 | Human papilloma virus replication inhibitors | Icosagen Cell Factory Oü (EE) | 2020-02-13 | — | — | US | disclosed |
| US-10543218-B2 | Human papilloma virus replication inhibitors | Icosagen Cell Factory Oü (EE) | 2020-01-28 | — | — | US | disclosed |
| US-20180133228-A1 | Human papilloma virus replication inhibitors | Icosagen Cell Factory Oü (EE) | 2018-05-17 | — | — | US | disclosed |
| US-20180133228-A1 | Human papilloma virus replication inhibitors | Icosagen Cell Factory Oü (EE) | 2018-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200046730-A1 | Human papilloma virus replication inhibitors | PCNA, CDKN1A, EIF2AK2 | RAB9A 2129/4885TBXA2R 4058/4885HTR3A 2673/4885 |
| US-20180133228-A1 | Human papilloma virus replication inhibitors | PCNA, CDKN1A, EIF2AK2 | RAB9A 2194/4885TBXA2R 4152/4885HTR3A 3723/4885 |
| US-11000529-B2 | Human papilloma virus replication inhibitors | PCNA, CDKN1A, EIF2AK2 | RAB9A 2129/4885TBXA2R 4058/4885HTR3A 2673/4885 |
| US-10543218-B2 | Human papilloma virus replication inhibitors | PCNA, CDKN1A, EIF2AK2 | RAB9A 2194/4885TBXA2R 4152/4885HTR3A 3723/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.